King Pharmaceuticals KG International — Cumulative paid loss and LAE, net of reinsurance

Other product segments

Similar metrics at other companies

HGInternational - Casualty — Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

$203.04M+570%

HGInternational - Specialty — Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

$674.98M+541%

HGInternational - Property — Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

$519.13M+282%

CNAInternational — Cumulative paid claims and allocated claim adjustment expense, net

$3.72B+487%

FRHCAccident Insurance — Cumulative paid losses and LAE, net of reinsurance

$245K+33.2%

WTMSpecialty — Cumulative Paid Loss and LAE, Net of Reinsurance

$411M+384%

Questions, answered.

What is King Pharmaceuticals's international — cumulative paid loss and LAE, net of reinsurance?

King Pharmaceuticals (KG) reported international — cumulative paid loss and LAE, net of reinsurance of 53,448,800,000% in Q4 2025.

How has King Pharmaceuticals's international — cumulative paid loss and LAE, net of reinsurance changed year-over-year?

King Pharmaceuticals's international — cumulative paid loss and LAE, net of reinsurance increased by 733.4% year-over-year, from 6,413,000,000% to 53,448,800,000%.

What does international — cumulative paid loss and LAE, net of reinsurance mean?

This metric tracks the total cash outflows for claims and loss adjustment expenses paid by the international segment, net of reinsurance recoveries, since the inception of the covered policies. It provides a historical view of actual claim settlement activity and cash flow requirements. This data is vital for validating the maturity of the loss portfolio and the accuracy of long-term reserve estimates.